Search


UK MHRA Guidance: Clinical Trials in the UK: Quality, Risk Proportionality, GMP, and Radiopharmaceutical IMPs
The UK regulatory landscape for clinical trials is undergoing a significant transformation with the implementation of updated Medicines for Human Use (Clinical Trials) Regulations, effective from 28 April 2026. These changes emphasize quality by design, risk-based approaches, and strengthened manufacturing standards, ensuring both participant safety and data integrity. Guidance: Clinical trials for medicines: Guidance on Quality and Risk Proportionality Scope This guidance ap

Sharan Murugan
Mar 292 min read
